(this.webpackJsonprhinotherm=this.webpackJsonprhinotherm||[]).push([[0],{72:function(e,t,i){},73:function(e,t,i){},76:function(e,t,i){},77:function(e,t,i){},78:function(e,t,i){},79:function(e,t,i){},80:function(e,t,i){},81:function(e,t,i){},86:function(e,t,i){"use strict";i.r(t);var s=i(0),a=i(22),n=i.n(a),r=i(37),c=i(9),l=(i(72),i(90)),o=(i(73),i(1));var d=function(e){return Object(o.jsxs)("div",{className:"home",children:[Object(o.jsxs)("div",{className:"first",children:[Object(o.jsx)("div",{className:"left",children:Object(o.jsx)("div",{className:"hyper",children:Object(o.jsxs)("div",{children:[Object(o.jsx)("h3",{children:"HYPERTHERMIA IS EFFECTIVE"}),Object(o.jsx)("h3",{children:"IN THE TREATMENT OF NASAL CONGESTION."})]})})}),Object(o.jsx)("div",{className:"right"})]}),Object(o.jsxs)("div",{className:"two",children:[Object(o.jsxs)("h3",{className:"title",children:[Object(o.jsx)("div",{children:"RHINOTHERM"}),Object(o.jsx)("div",{children:"IS BASED ON"})]}),Object(o.jsxs)("div",{children:[Object(o.jsx)("p",{children:"Briefly the scientific rationale of Rhinotherm is based on the work of Prof. Andre Lwoff (Pasteur Institute - France) who studied the effects of temperature on the development of viruses, and later work of researches from the Weizmann Institute of Science (Israel) which discovered that Hyperthermia is effective in the treatment of Nasal Congestion. The company has further developed this concept into an advanced and robust technology."}),Object(o.jsx)(l.a,{type:"primary",ghost:!0,onClick:function(){window.document.screenTop=0,e.history.push({pathname:"/about"})},children:"READ MORE"})]})]}),Object(o.jsxs)("div",{className:"three",children:[Object(o.jsxs)("dl",{children:[Object(o.jsx)("dt",{children:Object(o.jsx)("span",{})}),Object(o.jsxs)("dd",{children:[Object(o.jsx)("h3",{onClick:function(){e.history.push({pathname:"/lwoff"})},children:"ABOUT Andr\xe9 Lwofff"}),'The Nobel Prize in Physiology or Medicine 1965 Born: 8 May 1902, Ainay-le-Ch\xe2teau, France Died: 30 September 1994, Paris, France Affiliation at the time of the award: Institut Pasteur, Paris, France Prize motivation: "for their discoveries concerning genetic control of enzyme and virus synthesis." Professor Andre Lwoff studied the effects of temperature on virus development and infection, and the Research team in Israel discovered that hyperthermia was effective in nasal congestion.']})]}),Object(o.jsxs)("dl",{children:[Object(o.jsx)("dt",{children:Object(o.jsx)("span",{})}),Object(o.jsxs)("dd",{children:[Object(o.jsx)("h3",{onClick:function(){e.history.push({pathname:"/institute"})},children:"ABOUT WEIZMANN INSTITUTE"}),Object(o.jsx)("p",{children:"The Weizmann Institute of Science is one of the world\u2019s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel and Founder of the Institute"}),Object(o.jsx)("p",{children:"The Weizmann Institute has a long history of investigation and discovery rooted in a mission of advancing science for the benefit of humanity. In parallel, it educates a substantial proportion of Israel\u2019s scientific leadership and advances science literacy in schools and among the public."})]})]})]}),Object(o.jsx)("div",{className:"four",children:Object(o.jsxs)("div",{className:"content",children:[Object(o.jsxs)("div",{className:"left",children:[Object(o.jsx)("h3",{className:"title four-title",onClick:function(){e.history.push({pathname:"/product"})},children:"RHINOTHERM ULTRA III"}),Object(o.jsx)("p",{children:"Is a novel medical device designed for the consumer market and can be used in every home, school, office and geriatric care for the treatment of, Nasal congestion, Allergies, Sinusitis and more. The unique device is a Natural alternative for using drugs to treat nasal congestion symptoms. The Rhinotherm Ultra 3 device is a new generation of a previous model which had been sold to clinicians around the world. Several years of development resulted in an improved technology and re-designed device suitable to the private consumer. The device is based on hyperthermia technology, operates on highly important principle of delivering 100% water- saturated pressurized air at a temperature around 43\xb0C (110\xb0F) directly to the nasal passages via a hand-held tube. Duration of a treatment is only 20 to 25 minutes and on average offers the patient a fast relief that can last up to several days even several weeks. When suffering from Nasal congestion or during allergy season, between two or three treatments per day are recommended for maximum relief."})]}),Object(o.jsxs)("div",{className:"right",children:[Object(o.jsx)("span",{className:"img"}),Object(o.jsx)("div",{className:"content",children:Object(o.jsx)("p",{children:"delivering 100% water- saturated pressurized air at a temperature around 43\xb0C (110\xb0F) directly to the nasal passages via a hand-held tube."})})]})]})}),Object(o.jsxs)("div",{className:"five",children:[Object(o.jsxs)("div",{className:"title",onClick:function(){e.history.push({pathname:"/studies"})},children:[Object(o.jsx)("h3",{children:"CLINICAL"}),Object(o.jsx)("h3",{children:"STUDIES"})]}),Object(o.jsxs)("div",{className:"text",children:[Object(o.jsx)("p",{children:"Clinical studies conducted in USA, Germany, Italy, the Netherlands, UK, Israel and Japan showed impressive results in treating both children and adults suffering from all kinds of nasal congestion, including viral congestion, chronic congestion, sinusitis and allergies\u3002"}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"Double blind prospective design"}),Object(o.jsx)("li",{children:"990 participants"}),Object(o.jsx)("li",{children:"Israel, U.K, France, Germany, Italy ,Holland, Japan"}),Object(o.jsx)("li",{children:"75%-80% reported significant symptom relief"})]})]})]})]})};i(76);var h=function(){return Object(o.jsxs)("div",{className:"about",children:[Object(o.jsx)("div",{className:"first"}),Object(o.jsxs)("div",{className:"two",children:[Object(o.jsx)("h3",{className:"title",children:"RHINOTHERM "}),Object(o.jsx)("p",{children:"Established in 1985, developed and patented medical device to treat patients suffering from nasal congestion. The devices work by delivering 100% water-saturated pressurized air at a temperature of about 43 \u2103 (110F) directly to the nasal passages. This quick and easy treatment offers patients fast relief and which can last up to several weeks and improving rhinitis symptoms and nasal airflow. "}),Object(o.jsx)("p",{children:"Rhinotherm Ultra Devices, have been subjected to clinical studies in 10 countries and found to be an effective Drug-free source of relief for symptoms caused by nasal congestion associated with the allergic rhinitis and sinusitis."})]}),Object(o.jsxs)("div",{className:"three",children:[Object(o.jsx)("h3",{children:"CERTIFICATES AND APPROVED"}),Object(o.jsx)("p",{className:"img"}),Object(o.jsx)("p",{children:"FDA, CE, TUV. ISO 9001 13485... "})]})]})};i(77);var j=function(){return Object(o.jsxs)("div",{className:"lwoff",children:[Object(o.jsxs)("div",{className:"first",children:[Object(o.jsxs)("div",{className:"right",children:[Object(o.jsx)("p",{children:"The Nobel Prize in Physiology or Medicine 1965 Born: 8 May 1902, Ainay-le-Ch\xe2teau, France Died: 30 September 1994, Paris, France"}),Object(o.jsx)("p",{children:'Affiliation at the time of the award: Institut Pasteur, Paris, France Prize motivation: "for their discoveries concerning genetic control of enzyme and virus synthesis." Prize share: 1/3'})]}),Object(o.jsxs)("dl",{children:[Object(o.jsx)("dt",{}),Object(o.jsx)("dd",{children:Object(o.jsx)("h3",{children:"Andr\xe9 Lwoff "})})]})]}),Object(o.jsxs)("div",{className:"two",children:[Object(o.jsx)("h3",{className:"title",children:"WORK"}),Object(o.jsx)("p",{children:"Bacteriophages are viruses that attach themselves to bacteria, emptying their genetic material into them. At times, many new phage are created quickly, while at other times, new phage are formed only several bacterial generations later. In the early 1950s Andr\xe9 Lwoff successfully explained how this process, known as lysogeny, works. The bacteriophage's genes are incorporated into the bacteria's genetic material, but remain latent until a trigger factor causes new phage to be formed. Andr\xe9 Lwoff also showed that ultraviolet light can be one such factor."}),Object(o.jsx)("p",{children:"Professor Andre Lwoff studied the effects of temperature on virus development and infection, and the Research team in Israel discovered that hyperthermia was effective in nasal congestion."}),Object(o.jsx)("h4",{children:"Treatment of Perenial Allergic Rhinitis by Local Hyperthermia "}),Object(o.jsx)("p",{children:"Aharon Yerushalmi, Sergiu Karman and Andre Lwoff   Israel/France"}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"\u2014  95 patients (53 males 42 females)"}),Object(o.jsx)("li",{children:"\u2014  Mean age 32 (12-72)"}),Object(o.jsx)("li",{children:"\u2014  Typical complaints for at least one year"}),Object(o.jsx)("li",{children:"\u2014  Positive skin tests (at least one allergen)"}),Object(o.jsx)("li",{children:"\u2014  Exclusion criteria \u2013 steroid treatment, sinusitis, asthma, anatomic obstruction, respiratory infection"}),Object(o.jsx)("li",{children:"\u2014  Double blind randomized prospective trial"}),Object(o.jsx)("li",{children:"\u2014  Treatment group \u2013 43\u2103 air, Placebo group \u2013 room temperature air"}),Object(o.jsx)("li",{children:"\u2014  three 30 min sessions (2 hour interval) in one day"}),Object(o.jsx)("li",{children:"\u2014   F/U 1, 7, 30 days"})]}),Object(o.jsxs)("div",{className:"img",children:[Object(o.jsx)("span",{}),Object(o.jsx)("span",{})]})]})]})};i(78);var m=function(){return Object(o.jsxs)("div",{className:"studies",children:[Object(o.jsx)("div",{className:"first",children:Object(o.jsxs)("div",{className:"text",children:[Object(o.jsxs)("div",{className:"title",children:[Object(o.jsx)("h3",{children:"NASAL HYPERTHERMIA AND SIMPLE IRRIGATION FOR"}),Object(o.jsx)("h3",{children:"PERENNIAL RHINITIS \u2013 CHANGES IN INFLAMMATORY MEDIATORS"})]}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"Conducted by : John W. Georgitis"}),Object(o.jsx)("li",{children:"Bowman Gray School of Medicine of Wake Forest University"}),Object(o.jsx)("li",{children:"Winston-Salem, North Carolina, U.S.A"})]})]})}),Object(o.jsxs)("div",{className:"two",children:[Object(o.jsx)("p",{children:"Local hyperthermia or inhalation of heated water vapor is often recommended as a home remedy for various nasal disorders such as the common cold and allergic rhinitis."}),Object(o.jsx)("p",{children:"With technical advances in vapor generation(as tested with RHINOTHERM ULTRA II) , water can be heated to a range of 41\u2103 to 43\u2103 / (110\xb0F) with variation in particle size."}),Object(o.jsx)("p",{children:"The effect of inhaled heated vapor(as tested with RHINOTHERM ULTRA II) treatments was studied in patients with perennial rhinitis for changes in nasal airflow and patient perception of symptoms."}),Object(o.jsx)("p",{children:"Thirty symptomatic patients underwent three treatments at weekly intervals: (1) a large particle heated water vapor (as tested with RHINOTHERM ULTRA II) at 43\u2103 / (110\xb0F) for 20 minutes with a particle size of 4 to 8 microns, (2) a molecular water vapor at 41\u2103 for 20 minutes which is a vapor phase, and (3) nasal irrigation."}),Object(o.jsx)("p",{children:"Nasal airflow increased after both vapor treatments at four and six hours (P < .05) whereas airflow decreased after simple nasal irrigation treatment."}),Object(o.jsx)("p",{children:"Rhinitis symptoms improved after vapor(as tested with RHINOTHERM ULTRA II) treatments but not with nasal irrigation. Patients preferred the molecular water vapor(as tested with RHINOTHERM ULTRA II) treatment over the large particle vapor treatment and nasal irrigation by 2:1 margin."}),Object(o.jsx)("p",{children:"This study demonstrated the usefulness of heated vapor(as tested with RHINOTHERM ULTRA II) treatments in improving rhinitis symptoms and nasal airflow."}),Object(o.jsx)("h5",{children:"As Noted in the Full Original Study*"}),Object(o.jsx)("p",{children:'"This study evaluated two different heated vapor treatments compared with simple nasal lavage or irrigation since saline solution nasal sprays have been reported to be beneficial for rhinitis.'}),Object(o.jsx)("p",{children:'The heated treatments were at 41\u2103 for 20 min with a molecular water vapor, at 43\u2103 / (110\xb0F) for 20 min with a large particle water vapor ( RhinoTherm), and simple nasal irrigation (using a Water Pik) at temperature of 39\u2103."'}),Object(o.jsx)("h4",{children:"Three groups:"}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"1-Hot air -large particles \u2013 Rhinotherm"}),Object(o.jsx)("li",{children:"2-Hot air - small particles"}),Object(o.jsx)("li",{children:"3-Nasal lavage"})]}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"Baseline lavage before treatment and 30min, 2, 4, 6h after treatment for mediator collection"}),Object(o.jsx)("li",{children:"Typical complaints and positive skin tests"}),Object(o.jsx)("li",{children:"No anti inflammatory drugs during the study"}),Object(o.jsx)("li",{children:"Exclusion criteria \u2013 sinusitis, septal deviation, URI, asthma"}),Object(o.jsx)("li",{children:"Histamin, Leukotriene C4 D4 E4 and Prostaglandin D2"})]}),Object(o.jsxs)("p",{children:[Object(o.jsx)("span",{}),Object(o.jsx)("span",{})]})]}),Object(o.jsxs)("div",{className:"three",children:[Object(o.jsxs)("div",{className:"title",children:[Object(o.jsx)("h3",{children:"EFFECTS OF THE LOCAL HYPERTHERMIA"}),Object(o.jsx)("h3",{children:"ON THE UPPER AIRWAY MUCOSA MAKOTO"}),Object(o.jsx)("h3",{children:"HASHIMOTO ET ALL"})]}),Object(o.jsxs)("div",{children:[Object(o.jsx)("div",{children:"Department of Otolaryngology"}),Object(o.jsx)("div",{children:"JAPAN"})]}),Object(o.jsx)("h5",{children:"The results obtained were as follows:"}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"1. During the nasal local hyperthermia, the temperature in the nasal airway up to the nasopharynx remained at above 43\xb0C."}),Object(o.jsx)("li",{children:"2. The mean temperature on the surface of the nasal mucosa was from 37\xb0C to 38\xb0C"}),Object(o.jsx)("li",{children:"3. The mucociliary activity in vivo was not disturbed by the hyperthermic load at 43\xb0C"})]}),Object(o.jsx)("h5",{children:"We conclude , from these results, that the nasal local hyperthermia is applicable without the disturbance of the mucociliary activity, and that the local circulation of the blood and the autonomic nervous system also should be considerable as the mechanism of this treatment."}),Object(o.jsx)("p",{})]}),Object(o.jsxs)("div",{className:"four",children:[Object(o.jsxs)("div",{className:"title",children:[Object(o.jsx)("h3",{children:"THERAPEUTIC EFFECT OF RHINITIS"}),Object(o.jsx)("h3",{children:"AND HYPERTHERMIA ON CHILDREN WITH RHINITIS"})]}),Object(o.jsxs)("div",{children:[Object(o.jsx)("div",{children:"GAO Ying \xa0Department of Otorhinolaryngology,"}),Object(o.jsx)("div",{children:"Dalian Children\u02bcs Hospital (Liaoning "})]}),Object(o.jsxs)("ul",{children:[Object(o.jsxs)("li",{children:[Object(o.jsx)("span",{}),Object(o.jsx)("span",{})]}),Object(o.jsx)("li",{})]})]})]})};i(79);var b=function(){return Object(o.jsxs)("div",{className:"product",children:[Object(o.jsxs)("div",{className:"first",children:[Object(o.jsx)("div",{className:"img"}),Object(o.jsx)("div",{className:"center",children:Object(o.jsx)("h2",{children:"ALLERGIC RHINITIS "})}),Object(o.jsxs)("div",{className:"right",children:[Object(o.jsx)("p",{children:"Allergic Rhinitis"}),Object(o.jsx)("p",{children:"Sketch Map"}),Object(o.jsx)("span",{className:"img"})]})]}),Object(o.jsx)("div",{className:"two",children:Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"\u2014  Allergic reaction to variety of chemicals (Dust mite, Molds, Plants, Fur\u2026.)"}),Object(o.jsx)("li",{children:"\u2014  Perennial and seasonal forms"}),Object(o.jsx)("li",{children:"\u2014  Local inflammatory reaction \u2013 variety of cytokins"}),Object(o.jsx)("li",{children:"\u2014  Medications \u2013 local and systemic steroids, antihistamines"}),Object(o.jsx)("li",{children:"\u2014  Treatment side effects \u2013 drowsiness, epistaxis, nasal mucosal dryness, systemic steroids side effects (high BP, osteoporosis, cardiac disease, diabetes\u2026)"})]})}),Object(o.jsxs)("div",{className:"three",children:[Object(o.jsx)("h3",{className:"title",children:"HYPERTHERMIA METHOD "}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"Heated, humidified air has been used since the invention of the steam kettle."}),Object(o.jsx)("li",{children:"Humidified air at 43\xb0C (110\xb0F) is an effective treatment for Allergic rhinitis   that does not damage the nasal mucosa."})]})]}),Object(o.jsxs)("div",{className:"four",children:[Object(o.jsx)("h3",{className:"title",children:"DEVICE DEVELOPMENT"}),Object(o.jsx)("p",{children:"RHINOTHERM based on the work of:"}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"Professor Andre Lwoff, 1965 Nobel Prize winner (Pasteur Institute of Paris) - studied the effects of temperature on virus development and infection."}),Object(o.jsx)("li",{children:"Dr. A. Yerushalmi from the Weizmann Institute of Science."}),Object(o.jsx)("li",{children:"Research team in Israel discovered that hyperthermia was effective in nasal congestion. RHINOTHERM development."}),Object(o.jsx)("li",{children:"Improved technology - reduced cost RHINOTHERM  for home use."})]})]}),Object(o.jsxs)("div",{className:"five",children:[Object(o.jsx)("h3",{className:"title",children:"RHINOTHERM PRODUCT PRINCIPLES "}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"Saturated 100% RH pressurized air at 43\xb0C (110\xb0F) directly to the nose at 28 L/Min."}),Object(o.jsx)("li",{children:"Constant hot airflow overcomes the Air- Conditioning effect of the nose"}),Object(o.jsx)("li",{children:"43\xb0C- Incompatible with\u201clife temperature\u201d"}),Object(o.jsx)("li",{children:"Duration of  treatment 15 to 30 minutes"}),Object(o.jsx)("li",{children:"Symptom relief for several days up to one month."}),Object(o.jsx)("li",{children:"RHINOTHERM = Drug Free Treatment."}),Object(o.jsx)("li",{children:"Low cost \u2013 home, office, schools, hospitals"})]})]}),Object(o.jsxs)("div",{className:"six",children:[Object(o.jsx)("h3",{className:"title",children:"RHINOTHERM ULTRA II"}),Object(o.jsxs)("dl",{children:[Object(o.jsx)("dt",{}),Object(o.jsxs)("dd",{children:[Object(o.jsx)("p",{children:"Most people who suffer from allergy symptoms find relief with antihistamines and traditional cold relief medicine. These can often cause unwanted and uncomfortable side effects to the point where many people would rather suffer with the symptoms than use the remedy. But now there is a new source of relief, which uses no drugs, just water or saline solution, thus preventing adverse side effects caused by drugs. Based on the principle of hyperthermia, water- saturated pressurized air is delivered directly to the nasal passages."}),Object(o.jsx)("p",{children:'This new relief is the "Rhinotherm Ultra 2." Developed by a team of scientists and engineers, the Rhinotherm has proven to be effective for relieving the nasal congestion in numerous clinical studies performed worldwide. Relief after a 15 to 30 minutes treatment can last up to several days. The temperature of the water and the duration of treatment are monitored by a small digital unit on the appliance.'}),Object(o.jsx)("p",{children:"The Rhinotherm appliance was subjected to over ten clinical trials (some of them on a randomized double-blind basis), conducted in eight countries, ranging from Japan and China in the East to Europe and Canada in the West, and was successful in over 75% of the cases in increasing nasal patency and decreasing nasal discharge. An asthmatic attack occurred in less than 1% of asthmatic patients during treatment."}),Object(o.jsx)("p",{children:'The "Rhinothemi Ultra 2" can be used by both adults and children, although pregnant women should consult their physicianf.'})]})]})]}),Object(o.jsxs)("div",{className:"seven",children:[Object(o.jsx)("h3",{className:"title",children:"RHINOTHERM ULTRA III"}),Object(o.jsxs)("dl",{children:[Object(o.jsx)("dt",{}),Object(o.jsxs)("dd",{children:[Object(o.jsx)("p",{children:"Is a novel medical device designed for the consumer market and can be used in every home, school, office and geriatric care for the treatment of Nasal congestion, Allergies, Sinusitis and more."}),Object(o.jsx)("p",{children:"The unique device is a Natural alternative for using drugs to treat nasal congestion symptoms. The Rhinotherm Ultra 3 device is a new generation of a previous model which had been sold to clinicians around the world."}),Object(o.jsx)("p",{children:"Several years of development resulted in an improved technology and re-designed device suitable to the private consumer."}),Object(o.jsx)("p",{children:"The device is based on hyperthermia technology, operates on highly important principle of delivering 100% water- saturated pressurized air at a temperature around 43\xb0C (110\xb0F) directly to the nasal passages via a hand-held tube."}),Object(o.jsx)("p",{children:"Duration of a treatment is only 20 to 25 minutes and on average offers the patient a fast relief that can last up to several days even several weeks."}),Object(o.jsx)("p",{children:"When suffering from a Cold or during allergy season, between two or three treatments per week are recommended for maximum relief."})]})]})]}),Object(o.jsxs)("div",{className:"eight",children:[Object(o.jsx)("h4",{children:"HIGHLIGHTS"}),Object(o.jsxs)("ul",{children:[Object(o.jsx)("li",{children:"\u2014   Drug free treatment"}),Object(o.jsx)("li",{children:"\u2014   Long lasting relief from symptoms of common"}),Object(o.jsx)("li",{children:"\u2014   allergic rhinitis"}),Object(o.jsx)("li",{children:"\u2014   Free of side effects"}),Object(o.jsx)("li",{children:"\u2014   A Family device"})]})]})]})};i(80);var f=function(){return Object(o.jsxs)("div",{className:"institute",children:[Object(o.jsxs)("div",{className:"first",children:[Object(o.jsx)("div",{className:"right",children:Object(o.jsxs)("div",{children:[Object(o.jsx)("p",{children:"The Weizmann Institute of Science is one of the world\u2019s leading multidisciplinary basic research institutions in the natural and exact sciences."}),Object(o.jsx)("p",{children:"It is located in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel and Founder of the Institute."})]})}),Object(o.jsxs)("dl",{children:[Object(o.jsx)("dt",{}),Object(o.jsx)("dd",{children:Object(o.jsx)("h3",{children:"WEIZMANN INSTITUTE"})})]})]}),Object(o.jsxs)("div",{className:"two",children:[Object(o.jsxs)("div",{className:"title",children:[Object(o.jsx)("h3",{style:{margin:0},children:"FOUNDATIONS OF A COUNTRY AND"}),Object(o.jsx)("h3",{style:{margin:0},children:"A WORLD-CLASS INSTITUTION"})]}),Object(o.jsx)("p",{children:"The Weizmann Institute was founded by Dr. Chaim Weizmann (1874-1952) in 1934 as the Daniel Sieff Research Institute, named in memory of the son of U.K. donors Rebecca and Israel Sieff. The Institute was renamed in honor of Dr. Weizmann in 1949. Dr. Weizmann was a renowned chemist and ardent Zionist who saw his vision of the establishment of a Jewish state in the Land of Israel and of higher education in Israel all come to fruition during his lifetime. In partnership with others, he established the Hebrew University of Jerusalem in 1925 and the Weizmann Institute of Science."}),Object(o.jsx)("p",{children:"While working as a lecturer at the University of Manchester, Dr. Weizmann developed the process for producing acetone through bacterial fermentation, which was of great importance to the British during World War I. He worked with Lord Arthur James Balfour to write the Balfour Declaration in support of the establishment of the State of Israel and met with U.S. President Harry Truman to convince him to support the State\u2019s establishment. Dr. Weizmann became the first President of the State of Israel. His residence on the Weizmann Institute campus is now a museum and a national landmark."}),Object(o.jsx)("h3",{className:"title",children:"HISTORY: SELECTED MILESTONES"}),Object(o.jsx)("p",{children:"Dr. Chaim Weizmann\u2019s archives contain more than 200,000 documents including letters from Albert Einstein and Lord Arthur James Balfour"}),Object(o.jsx)("p",{children:"In 1941, Dr. Weizmann established the first pharmaceutical company in Israel, Palestine Pharmaceutical Products, Ltd."}),Object(o.jsx)("p",{children:"WEIZAC, the first computer in Israel, and one of the first in the world, was designed and built at the Weizmann Institute in 1954. It laid the foundations of Israel\u2019s booming computer industry."}),Object(o.jsx)("p",{children:"The Institute\u2019s Feinberg Graduate School was the first academic institution in Israel to teach computer science."}),Object(o.jsx)("p",{children:"The Weizmann Institute of Science was the first to introduce cancer research in Israel and the first to build particle accelerators."}),Object(o.jsx)("p",{children:"The Institute was the first to establish, in 1959, a technology transfer company, Yeda. To date, it has registered nearly 2,000 families of patents."}),Object(o.jsx)("p",{children:"Israel\u2019s first ethical drug, Copaxone\xae, developed at the Weizmann Institute of Science, received FDA approval in 1997."}),Object(o.jsx)("p",{children:"The Institute established the first hi-tech park in Israel, Kiryat Weizmann, adjacent to the campus."}),Object(o.jsx)("p",{children:"One Nobel laureate and three Turing Award laureates have been associated with the Weizmann Institute of Science."})]})]})},u=i(66),p=i(88),O=[{name:"HOME",key:"1",path:"/home"},{name:"ABOUT US",key:"2",path:"/about"},{name:"Andr\xe9 Lwoff",key:"3",path:"/lwoff"},{name:"WEIZMANN INSTITUTE",key:"4",path:"/institute"},{name:"PRODUCT",key:"5",path:"/product"},{name:"CLINICAL STUDIES",key:"6",path:"/studies"}],x=(i(81),p.a.TabPane);var v=function(e){var t=Object(s.useState)("1"),i=Object(u.a)(t,2),a=i[0],n=i[1],c=e.location.pathname;return Object(s.useEffect)((function(){O.map((function(e){e.path==c&&n(e.key)})),document.body.scrollTop=document.documentElement.scrollTop=0}),[c]),Object(o.jsxs)("div",{className:"wrap",children:[Object(o.jsxs)("div",{className:"header",children:[Object(o.jsx)("span",{className:"logo"}),Object(o.jsx)(p.a,{defaultActiveKey:"1",activeKey:a,children:O.map((function(e){return Object(o.jsx)(x,{tab:Object(o.jsx)(r.b,{to:e.path,children:e.name})},e.key)}))})]}),Object(o.jsx)("div",{className:"content",children:e.children}),Object(o.jsxs)("div",{className:"footer",children:[Object(o.jsx)("p",{children:"\xa9 Rhinotherm, 2005. All rights reserved"}),Object(o.jsx)("p",{children:"EMAIL: contact@rhinotherm.com.cn"})]})]})};n.a.render(Object(o.jsx)(r.a,{children:Object(o.jsx)(c.d,{children:Object(o.jsxs)(v,{children:[Object(o.jsx)(c.a,{exact:!0,from:"/",to:"/home"}),Object(o.jsx)(c.b,{path:"/home",component:d}),Object(o.jsx)(c.b,{path:"/about",component:h}),Object(o.jsx)(c.b,{path:"/lwoff",component:j}),Object(o.jsx)(c.b,{path:"/studies",component:m}),Object(o.jsx)(c.b,{path:"/product",component:b}),Object(o.jsx)(c.b,{path:"/institute",component:f})]})})}),document.getElementById("root"))}},[[86,1,2]]]);
//# sourceMappingURL=main.cb231376.chunk.js.map